Zaleplon

Generic Name
Zaleplon
Brand Names
Sonata
Drug Type
Small Molecule
Chemical Formula
C17H15N5O
CAS Number
151319-34-5
Unique Ingredient Identifier
S62U433RMH
Background

Zaleplon is a sedative/hypnotic, mainly used for insomnia. It is known as a nonbenzodiazepine hypnotic. Zaleplon interacts with the GABA receptor complex and shares some of the pharmacological properties of the benzodiazepines. Zaleplon is a schedule IV drug in the United States.

Indication

For the treatment of short-term treatment of insomnia in adults.

Associated Conditions
Insomnia
Associated Therapies
-
Clinical Trials
Related News

Zaleplon in HIV Patients With Depression

Phase 2
Completed
Conditions
HIV/AIDS
Clinical Depression
Interventions
Drug: Zaleplon
First Posted Date
2018-04-05
Last Posted Date
2018-10-16
Lead Sponsor
University of Pennsylvania
Target Recruit Count
20
Registration Number
NCT03489304
Locations
🇺🇸

Mood & Anxiety Disorders Research and Treatment Program, Philadelphia, Pennsylvania, United States

Cerebral MRI During Sleep

Completed
Conditions
Sleep
First Posted Date
2017-10-09
Last Posted Date
2019-03-14
Lead Sponsor
University of California, San Diego
Target Recruit Count
11
Registration Number
NCT03304652
Locations
🇺🇸

UC San Diego, San Diego, California, United States

Pharmacovigilance in Gerontopsychiatric Patients

Phase 3
Terminated
Conditions
Dementia
Depression
Schizophrenia
Psychosomatic Disorders
Anxiety Disorders
Interventions
Drug: Phenobarbital
Drug: Phenytoin
Drug: Carbamazepine
Drug: Oxcarbazepine
Drug: Valproic Acid
Drug: Lamotrigine
Drug: Topiramate
Drug: Gabapentin
Drug: Levetiracetam
Drug: Pregabalin
Drug: Lacosamide
Drug: Clonazepam
Drug: Biperiden
Drug: Levomepromazine
Drug: Fluphenazine
Drug: Perphenazine
Drug: Perazine
Drug: Thioridazine
Drug: Haloperidol
Drug: Melperone
Drug: Pipamperone
Drug: Bromperidol
Drug: Benperidol
Drug: Sertindole
Drug: Ziprasidone
Drug: Flupentixol
Drug: Chlorprothixene
Drug: Zuclopenthixol
Drug: Fluspirilene
Drug: Pimozide
Drug: Clozapine
Drug: Olanzapine
Drug: Quetiapine
Drug: Sulpiride
Drug: Tiapride
Drug: Amisulpride
Drug: Prothipendyl
Drug: Risperidone
Drug: Aripiprazole
Drug: Paliperidone
Drug: Diazepam
Drug: Oxazepam
Drug: Lorazepam
Drug: Bromazepam
Drug: Clobazam
Drug: Alprazolam
Drug: Hydroxyzine
Drug: Buspirone
Drug: Chloral Hydrate
Drug: Flurazepam
Drug: Nitrazepam
Drug: Triazolam
Drug: Lormetazepam
Drug: Temazepam
Drug: Midazolam
Drug: Brotizolam
Drug: Zopiclone
Drug: Zolpidem
Drug: Zaleplon
Drug: Melatonin
Drug: Clomethiazole
Drug: Diphenhydramine
Drug: Promethazine
Drug: Imipramine
Drug: Clomipramine
Drug: Opipramol
Drug: Trimipramine
Drug: Amitriptyline
Drug: Nortriptyline
Drug: Doxepin
Drug: Maprotiline
Drug: Amitriptyline oxide
Drug: Fluoxetine
Drug: Citalopram
Drug: Paroxetine
Drug: Sertraline
Drug: Fluvoxamine
Drug: Escitalopram
Drug: Tranylcypromine
Drug: Moclobemide
Drug: Mianserin
Drug: Trazodone
Drug: Mirtazapine
Drug: Bupropion
Drug: Venlafaxine
Drug: Reboxetine
Drug: Duloxetine
Drug: Agomelatine
Drug: Pyritinol
Drug: Piracetam
Drug: Donepezil
Drug: Rivastigmine
Drug: Galantamine
Drug: Memantine
Drug: Nicergoline
Drug: Acamprosate
Drug: Lithium
First Posted Date
2015-03-02
Last Posted Date
2018-02-28
Lead Sponsor
Hannover Medical School
Target Recruit Count
407
Registration Number
NCT02374567
Locations
🇩🇪

Bezirkskrankenhaus Augsburg, Augsburg, Germany

🇩🇪

Krankenhaus Hedwigshöhe, Berlin, Germany

🇩🇪

Hannover Medical School, Hannover, Germany

and more 2 locations

Hypnotic Medications and Memory: Effect of Drug Exposure During the Night

First Posted Date
2010-07-09
Last Posted Date
2014-08-26
Lead Sponsor
St. Luke's Hospital, Chesterfield, Missouri
Target Recruit Count
26
Registration Number
NCT01159652
Locations
🇺🇸

St. Luke's Hospital Sleep Medicine and Research Center, Chesterfield, Missouri, United States

Bioequivalency Study of Zaleplon 10 mg Capsules Under Fed Conditions

Not Applicable
Completed
Conditions
Short Term Treatment of Insomnia
First Posted Date
2008-06-10
Last Posted Date
2018-01-23
Lead Sponsor
Roxane Laboratories
Target Recruit Count
40
Registration Number
NCT00694317
Locations
🇺🇸

Novum Pharmaceutical Research Services, Houston, Texas, United States

Bioequivalency Study of Zaleplon 10 mg Capsules Under Fasting Conditions

Not Applicable
Completed
Conditions
Short Term Treatment of Insomnia
First Posted Date
2008-06-10
Last Posted Date
2018-01-23
Lead Sponsor
Roxane Laboratories
Target Recruit Count
39
Registration Number
NCT00694187
Locations
🇺🇸

Novum Pharmaceutical Research Services, Houston, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy